Which of the following is a component of atrial fibrillation management?

Prepare for the Adult CCRN Exam with flashcards and multiple choice questions, each question includes hints and explanations. Get ready for your certification test!

Multiple Choice

Which of the following is a component of atrial fibrillation management?

Explanation:
Rate-control therapy is a primary approach in atrial fibrillation management because the rapid ventricular response seen with AF reduces diastolic filling and cardiac output. By slowing AV nodal conduction, these medications—such as beta-blockers, non-dihydropyridine calcium channel blockers, or digoxin—lower the heart rate, improve ventricular filling, relieve symptoms, and help prevent tachycardia-induced cardiomyopathy. This approach is typically the first step in patients with a rapid ventricular response, stabilizing hemodynamics while considering rhythm control or anticoagulation as needed. Vasopressor therapy is used to treat hypotension or shock, not to control the AF rhythm. Renin inhibitors and diuretics do not directly address the rhythm management of AF, though diuretics may be used for volume management in heart failure.

Rate-control therapy is a primary approach in atrial fibrillation management because the rapid ventricular response seen with AF reduces diastolic filling and cardiac output. By slowing AV nodal conduction, these medications—such as beta-blockers, non-dihydropyridine calcium channel blockers, or digoxin—lower the heart rate, improve ventricular filling, relieve symptoms, and help prevent tachycardia-induced cardiomyopathy. This approach is typically the first step in patients with a rapid ventricular response, stabilizing hemodynamics while considering rhythm control or anticoagulation as needed. Vasopressor therapy is used to treat hypotension or shock, not to control the AF rhythm. Renin inhibitors and diuretics do not directly address the rhythm management of AF, though diuretics may be used for volume management in heart failure.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy